DalsnaFinance › IPOs › Bridgebio Pharma Inc › IPO
BridgeBio Pharma, Inc. completed its initial public offering on NASDAQ on June 27, 2019, pricing at $17.00 a share.
| Ticker | BBIO |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | June 27, 2019 |
| Offering price | $17.00 |
| Shares offered | 20,500,000 |
| Total raised | $349M |
BridgeBio Pharma, Inc. sold 20,500,000 shares at $17.00 each on NASDAQ. Multiplied out, that is $348.5 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $349 million total recorded for the deal.
BridgeBio Pharma, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for BridgeBio Pharma, Inc.. This page is general information, not investment advice.